Early research (Phase 1)Study completedNCT01957579
What this trial is testing
A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies
Who this might be right for
Blood CancerAdvanced B Cell Malignancies
AstraZeneca 32